Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Patro SC"'
Autor:
Joseph KW; University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA., Halvas EK; University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA., Brandt LD; University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA., Patro SC; HIV Dynamics and Replication Program, National Cancer Institutegrid.48336.3a, Frederick, Maryland, USA., Rausch JW; Basic Research Laboratory, Center for Cancer Research, National Cancer Institutegrid.48336.3a, Frederick, Maryland, USA., Chopra A; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia., Mallal S; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia.; University of Vanderbilt, Department of Medicine, Nashville, Tennessee, USA., Kearney MF; HIV Dynamics and Replication Program, National Cancer Institutegrid.48336.3a, Frederick, Maryland, USA., Coffin JM; Tufts Universitygrid.429997.8, Boston, Massachusetts, USA., Mellors JW; University of Pittsburgh, Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania, USA.
Publikováno v:
Journal of virology [J Virol] 2022 Jul 13; Vol. 96 (13), pp. e0012222. Date of Electronic Publication: 2022 Jun 08.
Autor:
Patro SC; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702, USA., Niyongabo A; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702, USA., Maldarelli F; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702, USA., Kearney MF; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702, USA.
Publikováno v:
Viruses [Viruses] 2021 Dec 10; Vol. 13 (12). Date of Electronic Publication: 2021 Dec 10.
Autor:
Varco-Merth, Benjamin1,2 (AUTHOR), Chaunzwa, Morgan1,2 (AUTHOR), Duell, Derick M.1,2 (AUTHOR), Marenco, Alejandra1,2 (AUTHOR), Goodwin, William1,2 (AUTHOR), Dannay, Rachel1,2 (AUTHOR), Nekorchuk, Michael1,2 (AUTHOR), Shao, Danica3 (AUTHOR), Busman-Sahay, Kathleen1,2 (AUTHOR), Fennessey, Christine M.4 (AUTHOR), Silipino, Lorna4 (AUTHOR), Hull, Michael4 (AUTHOR), Bosche, William J.4 (AUTHOR), Fast, Randy4 (AUTHOR), Oswald, Kelli4 (AUTHOR), Shoemaker, Rebecca4 (AUTHOR), Bochart, Rachele2 (AUTHOR), MacAllister, Rhonda2 (AUTHOR), Labriola, Caralyn S.1,2 (AUTHOR), Smedley, Jeremy V.1,2 (AUTHOR)
Publikováno v:
PLoS Pathogens. 8/22/2024, Vol. 20 Issue 8, p1-28. 28p.
Autor:
Rausch JW; HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702., Capoferri AA; HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.; Microbiology and Immunology Department, Georgetown University, Washington, DC 20007., Katusiime MG; HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702., Patro SC; HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702., Kearney MF; HIV Dynamics & Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702; kearneym@mail.nih.gov.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Oct 06; Vol. 117 (40), pp. 24614-24616. Date of Electronic Publication: 2020 Sep 21.
Autor:
Patro SC; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702; sean.patro@nih.gov john.coffin@tufts.edu., Brandt LD; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Bale MJ; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Halvas EK; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Joseph KW; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Shao W; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Wu X; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Guo S; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, 171 65 Stockholm, Sweden., Wiegand A; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Spindler J; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Raley C; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Hautman C; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Sobolewski M; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Fennessey CM; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Hu WS; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Luke B; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Hasson JM; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Niyongabo A; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Capoferri AA; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Keele BF; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702., Milush J; Department of Medicine, University of California, San Francisco, CA 94143., Hoh R; Department of Medicine, University of California, San Francisco, CA 94143., Deeks SG; Department of Medicine, University of California, San Francisco, CA 94143., Maldarelli F; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Hughes SH; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702., Coffin JM; Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111; sean.patro@nih.gov john.coffin@tufts.edu., Rausch JW; Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702., Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Kearney MF; HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Dec 17; Vol. 116 (51), pp. 25891-25899. Date of Electronic Publication: 2019 Nov 27.
HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus.
Autor:
Musick A; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Spindler J; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Boritz E; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States., Pérez L; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States., Crespo-Vélez D; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute for Allergies and Infectious Diseases (NIAID), Bethesda, MD, United States., Patro SC; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Sobolewski MD; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Bale MJ; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Reid C; Frederick National Laboratory for Cancer Research, Aquired Immunodeficiency Syndrome (AIDS) and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick, MD, United States., Keele BF; Frederick National Laboratory for Cancer Research, Aquired Immunodeficiency Syndrome (AIDS) and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick, MD, United States., Capoferri A; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Shao W; Frederick National Laboratory for Cancer Research, Advanced Biomedical Computing Center, Leidos Biomedical Research, Inc., Frederick, MD, United States., Wiegand A; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Simonetti FR; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Hughes SH; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Coffin JM; Department of Molecular Biology and Microbiology, Tufts University, Boston, MA, United States., Maldarelli F; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States., Kearney MF; Human Immunodeficiency Virus (HIV) Dynamics and Replication Program, Center for Cancer Research (CCR), National Cancer Institute (NCI)-Frederick, Frederick, MD, United States.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2019 Oct 01; Vol. 10, pp. 2204. Date of Electronic Publication: 2019 Oct 01 (Print Publication: 2019).
Autor:
McManus WR; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Bale MJ; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Spindler J; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Wiegand A; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Musick A; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Patro SC; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Sobolewski MD; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Musick VK; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Anderson EM; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Cyktor JC; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Halvas EK; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Shao W; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Wells D; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Wu X; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Keele BF; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Milush JM; Department of Medicine, UCSF, San Francisco, California, USA., Hoh R; Department of Medicine, UCSF, San Francisco, California, USA., Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hughes SH; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA., Deeks SG; Department of Medicine, UCSF, San Francisco, California, USA., Coffin JM; Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA., Kearney MF; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2019 Jul 30; Vol. 129 (11), pp. 4629-4642. Date of Electronic Publication: 2019 Jul 30.
Autor:
Mbonye, Uri1 (AUTHOR) uri.mbonye@case.edu, Karn, Jonathan1 (AUTHOR) jonathan.karn@case.edu
Publikováno v:
Retrovirology. 4/5/2024, Vol. 21 Issue 1, p1-38. 38p.
Autor:
Patro SC; HIV Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, Pennsylvania, USA; Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA;, Azzoni L; HIV Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, Pennsylvania, USA;, Joseph J; HIV Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, Pennsylvania, USA;, Fair MG; HIV Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, Pennsylvania, USA;, Sierra-Madero JG; Departmento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico Distrito Federal, Mexico; and., Rassool MS; Clinical HIV Research Unit, Department of Internal Medicine, Faculty of Heath Sciences, University of the Witwatersrand, Johannesburg, South Africa., Sanne I; Clinical HIV Research Unit, Department of Internal Medicine, Faculty of Heath Sciences, University of the Witwatersrand, Johannesburg, South Africa., Montaner LJ; HIV Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, Pennsylvania, USA; montaner@wistar.org.
Publikováno v:
Journal of leukocyte biology [J Leukoc Biol] 2016 Jul; Vol. 100 (1), pp. 223-31. Date of Electronic Publication: 2015 Nov 25.
Autor:
Patro SC; The Wistar Institute, HIV Immunopathogenesis Laboratory, Philadelphia, Pennsylvania, USA University of Pennsylvania Perelman School of Medicine, Department of Microbiology, Philadelphia, Pennsylvania, USA., Pal S; The Wistar Institute, Center for Systems and Computational Biology, Philadelphia, Pennsylvania, USA., Bi Y; The Wistar Institute, Center for Systems and Computational Biology, Philadelphia, Pennsylvania, USA., Lynn K; UPENN-Presbyterian Medical Center, Philadelphia, Pennsylvania, USA., Mounzer KC; Philadelphia FIGHT, The Jonathan Lax Treatment Center, Philadelphia, Pennsylvania, USA., Kostman JR; UPENN-Presbyterian Medical Center, Philadelphia, Pennsylvania, USA., Davuluri RV; The Wistar Institute, Center for Systems and Computational Biology, Philadelphia, Pennsylvania, USA., Montaner LJ; The Wistar Institute, HIV Immunopathogenesis Laboratory, Philadelphia, Pennsylvania, USA.
Publikováno v:
Journal of virology [J Virol] 2015 Jul; Vol. 89 (13), pp. 6970.